Login / Signup

Loss of HER2 after HER2-targeted treatment.

Tanja IgnatovFranceska GorbunowHolm EggemannOlaf OrtmannAtanas Ignatov
Published in: Breast cancer research and treatment (2019)
The interval between anti-HER2 treatment and the determination of HER2 in second histology is strongly associated with HER2 expression.
Keyphrases
  • poor prognosis
  • combination therapy
  • mass spectrometry
  • replacement therapy
  • smoking cessation